sefulness of the Kupffer phase study of contrast-enhanced ultrasound using Sonazoid for detection of hepatocellular carcinoma.
Not Applicable
- Conditions
- Hepatitis patients due to alcoholic or virus with the platelet count is under 150,000 /ul
- Registration Number
- JPRN-UMIN000006226
- Lead Sponsor
- Osaka Socio-Medical Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity to egg yolk 2) Pregnant or lactating women and women who may be pregnant 3) Severe liver dysfunction(AST, ALT,or BIL level >10ULN 4) Associated with HCC 5) Paients receiving interferon 6) Age under 20 7) Judged by investigator not to be appropriate for inclusion in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of Hepatocellular carcinoma
- Secondary Outcome Measures
Name Time Method Size of tumor Numbers of tumor Detection of focal liver lesion